Recent Quotes
Earnings
see more| Q1 2021 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-05-06 | ||||||
| REV | |||||||
| Q4 2020 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2021-03-26 | ||||||
| REV | |||||||
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Related Companies
| Ticker | Company | Price | Change | Chg % | Mkt Cap | |
|---|---|---|---|---|---|---|
| MNPR | Monopar Therapeutics | 7.39 | -0.35 | -4.52% | 84.6M |
Monopar Therapeutics Company Questions & Answers
How do I buy Monopar Therapeutics (MNPR) stock?
You can purchase shares of Monopar Therapeutics (NASDAQ: MNPR) through any online brokerage.
Who are Monopar Therapeutics's (MNPR) main competitors?
Other companies in Monopar Therapeutics’s space includes: PolarityTE (NASDAQ:PTE), Cleveland BioLabs (NASDAQ:CBLI) and Biocept (NASDAQ:BIOC).
What is the target price for Monopar Therapeutics?
The latest price target for Monopar Therapeutics (NASDAQ: MNPR) was reported by Roth Capital on 2021-01-28. The analyst firm set a price target for 49.00 expecting MNPR to rise to within 12 months (a possible 563.06% upside). 2 analyst firms have reported ratings in the last year.
How much is Monopar Therapeutics (MNPR) stock ?
The stock price for Monopar Therapeutics (NASDAQ: MNPR) is $7.39 last updated Thu Feb 25 2021 21:00:02 GMT+0000 (Coordinated Universal Time).
When is the next Monopar Therapeutics (MNPR) dividend?
There are no upcoming dividends for Monopar Therapeutics.
When is Monopar Therapeutics (NASDAQ:MNPR) reporting earnings?
When is the upcoming split for MNPR?
There is no upcoming split for Monopar Therapeutics.